Abstract
In 1940, Albright et al [1] first observed an association between estrogen deprivation and loss of bone mass. Bone loss may be attributed to an increase in the sensitivity of bone to the resorbing action of parathyroid hormone (PTH), 1,25-dihydroxy-vitamin D3 or other bone-resorbing agents [2, 3], Higher values for calcium in serum and urinary excretion of calcium [4, 5] have been observed in postmenopausal women, supporting the theory of an increased bone resorption. The greatest loss of bone mass occurs during the first four to five years after the menopause [6] and affects predominantly trabecular bone [7, 8]. Estrogen replacement therapy prevents postmenopausal bone loss and attendant osteoporotic fractures [9–12], Any factor that irreversibly decreases bone mass in premenopausal women predisposes to the disease of osteoporosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Albright, F, Smith, PH, Richardson, AM (1941). Postmenopausal osteoporosis: its clinical features. JAMA, 116, 2465
Heaney, RP (1965). A unified concept of osteoporosis. Am J Med, 39. 877
Jasani, C, Nordin, BEC, Smith, DA and Swanson, I (1965). Spinal osteoporosis and the menopause. Proc Roy Soc, 58, 441
Young, MM and Nordin, BEC (1967). Effects of natural and artificial menopause on plasma and urinary calcium and phosphorus. Lancet, i, 118
Gallagher, JC, Young, MM and Nordin, BEC (1972). Effects of artificial menopause on plasma and urine calcium and phosphate. Clin Endocrinol, 1, 57
Lindsay, R and Herrington, BS (1983). Estrogens and osteoporosis. Sem Reprod Endocrinol, 1, 55
Horsman, A, Nordin, BEC, Aaron, J and Marshall, DH (1981). Cortical and trabecular osteoporosis and their relation to fractures in the elderly. In: DeLuca, HF, Frost, HM, Jee, WSS, Johnston, CC and Parfitt, AM (eds.) “Osteoporosis — Recent Advances in Pathogenesis and Treatment”, p.175. (Baltimore: University Park Press)
Genant, HK, Cann, CE, Ettinger, B and Gordan, GS (1982). Quantative computed tomography of vertebral spongiosa: a sensitive method for detecting early bone loss after oophorectomy. Ann Intern Med, 97, 699
Lindsay, R, Hart, DM, Aitken, JM, MacDonal, AB, Anderson, JB and Clarke, AC (1976). Long-term prevention of postmenopausal osteoporosis by oestrogen. Lancet, 1, 1038
Hutchinson, TA, Polansky, SM and Feinstein, AR (1979). Post-menopausal oestrogens protect against fractures of hip and distal radius. A case-control study. Lancet, 2, 705
Diddle, AW and Smith IQ (1984). Postmenopausal osteoporosis: the role of estrogens. Southern Med J, 77, 868
Christiansen, C, Christensen, MS, McNair, P, Hagen, C, Stocklund, K-E and Transbol, I (1980). Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females. Eur J Clin Invest, 10, 273
Matsuo, H, Arimura, A, Nair, RMG and Schally, AV (1971). Synthesis of the porcine LH- and FSH-releasing hormone by the solid-phase method. Biochem Biophys Res Commun, 45, 822
Schally, AV, Arimura, A, Baba, Y, Nair, RMG, Matsuo, H, Redding, TW and Debeljuk, L (1971). Isolation and properties of FSH and LH-releasing hormone. Biochem Biophys Res Commun, 43, 393
Price, PA, Parthemore, JG and Deftos, LJ (1980). New biochemical marker for bone metabolism. J Clin Invest, 66, 878
Deftos, LJ, Parthemore, JF and Price, PA (1981). The measurement by radioimmunoassay in plasma of bone GLA during treatment of bone diseases. Calcif Tissue Int, 33, 307
Bothe, V, Schmidt-Gayk, H, Armbruster, F-P and Mayer, E (1984). Assay for the diagnosis of hyper- and hypovitaminosis D. Ärztl Lab, 30, 151
Scharla, S, Schmidt-Gayk, H, Reichel, H and Mayer, E (1984). A sensitive and simplified radioimmunoassay for 1,25-dihydroxyvitamin D3. Clin Chim Acta, 142, 325
Bouillon, R, Van Baelen, H, Rombauts, W and De Moor, P (1976). Purification and characterisation of the human serum binding protein for 25-hydroxyvitamin D3 (transcalciferin): identity with group specific component (Gc). Eur J Biochem, 66, 285
Cameron, JR, and Sorenson, J (1963). Meaurement of bone mineral in vivo: an improved method. Science, 142, 230
Mazess, RB, Hanson, J, Kan, W, Madsen, M. Pele, N, Wilson, CR and Witt, RM (1974). Progress in dual photon absorptiometry of bone. In: Schmeling, P (ed.) “Proceedings, Symposium on Bone Mineral Determinations”, p. 40. (Studsvik Sweden: Aktiebolaget Atomenergi Publication)
Riggs, BL, Wahner, HW, Dunn, WL, Mazess, RB, Offord, KP and Melton III, LJ (1981). Differential changes in bone mineral density of the appendicular skeleton with aging: relationship to spinal osteoporosis. J Clin Invest, 67, 328
Riggs, BL, Wahner, HW, Seemen, E, Offord, KP, Dunn, WL, Mazess, RB, Johnson, KA and Melton, LJ, III (1982). Changes in bone mineral density of the proximal femur and spine with aging. J Clin Invest, 70, 716
Nordin, BEC (1976). In: Van Keep, PA, Greenblatt, RB and Furnet, MA (eds.) “Consensus on Menopausal Research”, p.48 (Lancaster: MTP Press)
Gallagher, JC, Riggs, BL, Jerpbak, M, and Arnaud, CD. (1980). The effect of age on serum immunoreactive parathyroid hormone in normal and osteoporotic women. J Lab Clin Med, 95, 373
Castillo, L, Tanaka, Y, DeLuca, HF and Sundle, ML (1977). The stimulation of 25-hydroxyvitamin D3-hydroxy1ase by estrogen. Arch Biochem Biophys, 179, 211
Gallagher, JC, Riggs, BL, and DeLuca, HF (1980). The effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis. J Clin Endocrinol Metab, 51, 1359
Gudmundsson, JA, Ljunghall, S, Bergquist, C, Wide, L and Nillius, SJ (1987). Increased bone turnover during gonadotropin releasing hormone superagonist-induced ovulation inhibition. J Clin Endocrinol Metab, 65, 159
Steingold, KA, Lu, JKH, Randle, D, Moore, JG, Judd, HL and Meldrum, DR (1985). Treatment of endometriosis with a long acting GnRH analog — a blind evaluation. Presented at the 32nd Annual Meeting, Society for Gynecology Investigation, Phoenix, Arizona
Delmas, PD, Brown, JP, Malaval, L, Eduard, C and Meunier, PJ (1984). In: Cohn, Fujita, Potts and Talmage (eds.) “Endocrine control of bone and calcium metabolism”, p.73. (Amsterdam: Elsevier Science Publishers)
Price, PA, Parthemore, JG and Deftos, LJ (1980). New biochemical maker for bone metabolism. J Clin Invest, 66, 878
Delmas, PD, Wahner, HW, Mann, KG, and Riggs, BL (1983). Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone Gla-protein. J Lab Clin Med, 102, 470
Genant, HK, and Cann, CE (1981). Vertebral mineral determination using quantitative computed tomography. In: DeLuca, HF, Frost, HM, Jee, WSS, Johnston, CC and Parfitt, AM (eds.) “Osteoporosis: Recent advances in pathogenesis and treatment”, p.37. (Baltimore: University Park Press)
Devogelaer, JP, Huaux, JP, Nagant de Deuxchaisness, C, Donnez, J and Thomas, K (1987). Differential effects of the GnRH agonist buserelin on the axial and the appendicular skeleton. Presented at the 9th Annual Scientific Meeting of the American Society for Bone and Mineral Research, June 6–9, Indianapolis
Cann, CE, Martin, MC, Genant, HK and Jaffe, RB (1984). Decreased spinal mineral content in amenorrheic women. JAMA, 251, 626
Parfitt, AM (1979). Quantum concept of bone remodeling and turnover: implications for the pathogenesis of osteoporosis. Calcif Tissue Int, 28, 1
Cann, CE, Henzl, M, Heinrichs, J and Burry, K (1987). Calcium aggravates GnRH agonist-induced bone loss. Presented at the 9th Annual Scientific Meeting of the American Society for Bone and Mineral Research, June 6–9, Indianapolis
Matta, WH, Shaw, RW, Hesp, R and Katz, D (1987). Hypogonadism induced by luteinising hormone releasing hormone agonist analogues: effects on bone density in premenopausal women. Brit Med J, 294, 1523
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Kluwer Academic Publishers
About this chapter
Cite this chapter
Waibel, S. et al. (1990). Effects of GnRH Agonist-Induced Ovarian Suppression on Calcium Homeostasis and Bone Metabolism in Premenstrual Women. In: Vickery, B.H., Lunenfeld, B. (eds) GnRH Analogues in Cancer and Human Reproduction. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0725-6_17
Download citation
DOI: https://doi.org/10.1007/978-94-009-0725-6_17
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6811-6
Online ISBN: 978-94-009-0725-6
eBook Packages: Springer Book Archive